103 related articles for article (PubMed ID: 37606371)
21. FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.
Vink FJ; Meijer CJLM; Hesselink AT; Floore AN; Lissenberg-Witte BI; Bonde JH; Pedersen H; Cuschieri K; Bhatia R; Poljak M; Oštrbenk Valenčak A; Hillemanns P; Quint WGV; Del Pino M; Kenter GG; Steenbergen RDM; Heideman DAM; Bleeker MCG
Clin Infect Dis; 2023 Feb; 76(3):e827-e834. PubMed ID: 35686306
[TBL] [Abstract][Full Text] [Related]
22. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
[TBL] [Abstract][Full Text] [Related]
23. Molecular Triage of Premalignant Lesions in Liquid-Based Cervical Cytology and Circulating Cell-Free DNA from Urine, Using a Panel of Methylated Human Papilloma Virus and Host Genes.
Guerrero-Preston R; Valle BL; Jedlicka A; Turaga N; Folawiyo O; Pirini F; Lawson F; Vergura A; Noordhuis M; Dziedzic A; Pérez G; Renehan M; Guerrero-Diaz C; De Jesus Rodríguez E; Diaz-Montes T; Rodríguez Orengo J; Méndez K; Romaguera J; Trock BJ; Florea L; Sidransky D
Cancer Prev Res (Phila); 2016 Dec; 9(12):915-924. PubMed ID: 27671338
[TBL] [Abstract][Full Text] [Related]
24. The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: A systematic review and meta-analysis.
Bowden SJ; Kalliala I; Veroniki AA; Arbyn M; Mitra A; Lathouras K; Mirabello L; Chadeau-Hyam M; Paraskevaidis E; Flanagan JM; Kyrgiou M
EBioMedicine; 2019 Dec; 50():246-259. PubMed ID: 31732479
[TBL] [Abstract][Full Text] [Related]
25. L1 gene methylation in high-risk human papillomaviruses for the prognosis of cervical intraepithelial neoplasia.
Oka N; Kajita M; Nishimura R; Ohbayashi C; Sudo T
Int J Gynecol Cancer; 2013 Feb; 23(2):235-43. PubMed ID: 23314283
[TBL] [Abstract][Full Text] [Related]
26. Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays.
Dippmann C; Schmitz M; Wunsch K; Schütze S; Beer K; Greinke C; Ikenberg H; Hoyer H; Runnebaum IB; Hansel A; Dürst M
Clin Epigenetics; 2020 Nov; 12(1):171. PubMed ID: 33176878
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
28. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
29. Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia.
Murakami I; Fujii T; Dan K; Saito M; Ohno A; Iwata T; Aoki D
J Clin Virol; 2013 Sep; 58(1):149-54. PubMed ID: 23871162
[TBL] [Abstract][Full Text] [Related]
30. Quantitative Measurement of L1 Human Papillomavirus Type 16 Methylation for the Prediction of Preinvasive and Invasive Cervical Disease.
Kottaridi C; Kyrgiou M; Pouliakis A; Magkana M; Aga E; Spathis A; Mitra A; Makris G; Chrelias C; Mpakou V; Paraskevaidis E; Panayiotides JG; Karakitsos P
J Infect Dis; 2017 Mar; 215(5):764-771. PubMed ID: 28170039
[TBL] [Abstract][Full Text] [Related]
31. Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia.
Wijetunga NA; Belbin TJ; Burk RD; Whitney K; Abadi M; Greally JM; Einstein MH; Schlecht NF
Gynecol Oncol; 2016 Sep; 142(3):566-73. PubMed ID: 27401842
[TBL] [Abstract][Full Text] [Related]
32. Correlation between Methylation of Human Papillomavirus-16 L1 Gene and Cervical Carcinoma in Uyghur Women.
Niyazi M; Sui S; Zhu K; Wang L; Jiao Z; Lu P
Gynecol Obstet Invest; 2017; 82(1):22-29. PubMed ID: 26954462
[TBL] [Abstract][Full Text] [Related]
33. Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.
Vasiljević N; Scibior-Bentkowska D; Brentnall AR; Cuzick J; Lorincz AT
Gynecol Oncol; 2014 Mar; 132(3):709-14. PubMed ID: 24508839
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia.
Lendvai Á; Johannes F; Grimm C; Eijsink JJ; Wardenaar R; Volders HH; Klip HG; Hollema H; Jansen RC; Schuuring E; Wisman GB; van der Zee AG
Epigenetics; 2012 Nov; 7(11):1268-78. PubMed ID: 23018867
[TBL] [Abstract][Full Text] [Related]
35. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.
Wu JH; Liang XA; Wu YM; Li FS; Dai YM
Oncol Rep; 2013 Jan; 29(1):125-32. PubMed ID: 23064448
[TBL] [Abstract][Full Text] [Related]
36. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy.
Hesselink AT; Heideman DA; Steenbergen RD; Gök M; van Kemenade FJ; Wilting SM; Berkhof J; Meijer CJ; Snijders PJ
Int J Cancer; 2014 Aug; 135(4):880-6. PubMed ID: 24474183
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a new HPV genotyping assay based on next-generation sequencing.
Yi X; Zou J; Xu J; Liu T; Liu T; Hua S; Xi F; Nie X; Ye L; Luo Y; Xu L; Du H; Wu R; Yang L; Liu R; Yang B; Wang J; Belinson JL
Am J Clin Pathol; 2014 Jun; 141(6):796-804. PubMed ID: 24838323
[TBL] [Abstract][Full Text] [Related]
38. LINE-1 hypermethylation in white blood cell DNA is associated with high-grade cervical intraepithelial neoplasia.
Barchitta M; Quattrocchi A; Maugeri A; Canto C; La Rosa N; Cantarella MA; Spampinato G; Scalisi A; Agodi A
BMC Cancer; 2017 Aug; 17(1):601. PubMed ID: 28854904
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
Yu LL; Chen W; Lei XQ; Qin Y; Wu ZN; Pan QJ; Zhang X; Chang BF; Zhang SK; Guo HQ; Qiao YL
Oncotarget; 2016 Apr; 7(16):21181-9. PubMed ID: 27029033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
